Why GM is Investing Almost $1 Billion in Combustion Engines While Others Go Electric
Why GM is Investing Almost $1 Billion in Combustion Engines While Others Go Electric originally appeared on Autoblog.
GM's been resolute, for the most part, on electrification. With the Silverado EV released and a mix of electric SUVs across the Chevy and Cadillac brands (Escalade iQ and Lyriq, Chevy Equinox and Blazer EV), the brand has committed harder than any other American automaker. That's not to say the automaker's commitment to internal combustion is gone, though. Tonawanda Propulsion, a GM-owned plant covering 190 acres and comprising three separate facilities, has received nearly $900 million in funding, securing over 850 jobs and production of GM's sixth-generation V8 engine.
View the 2 images of this gallery on the original article
The investment is important to a lot of people. 'This investment marks an exciting new chapter for our plant,' said Tara Wasik, the plant's director. "This is a testament to the hard work of the membership of Local 774,' said Raymond Jensen Jr. in an interview with local news. 'It's extremely important to the community, to the surrounding areas, and to New York State itself." The impressive sum of $888 million will go towards new machinery, equipment, tools, and renovations as part of the more than $1.5 billion GM has invested in New York State in the last 15 years. It's also hardly the first time in recent memory that GM has extended the V8's lifespan. In 2023, GM invested $579 million in its Flint, Michigan production site. There, too, V8 production will continue to chug along.
View the 2 images of this gallery on the original article
However, it doesn't account for the $300 million commitment made two years ago in union negotiations to produce electric vehicles, specifically at Tonawanda. And it's not the first area where GM has had to pump the brakes on EV endorsements. The company has sold off its stake in a battery production facility to its partner, LG Energy. In other areas, GM has pushed back against California's 2035 plan to eliminate sales of gas-only vehicles, which is now, by the way, completely dead. On the other hand, GM pushed into the number two spot for April EV sales, capturing nearly 15% of EV sales. Getting mixed signals? Us too, but we blame the current political and economic climate, not necessarily GM.
Outfitting the plant for V8 production is important for CEO Mary Barra, too. 'Our significant investments in GM's Tonawanda Propulsion plant show our commitment to strengthening American manufacturing and supporting jobs in the U.S.,' she said in a press release. She further emphasized the plant's importance to the brand, citing its 87 years of operation. The plant will finish production of GM's fifth-gen V8 before commencing work on the sixth-gen product.
This $888 million investment marks the largest single investment GM has ever made in an engine-producing facility. The fact that it happens to make V8s is almost irrelevant; it implies the combustion engine at large still has several decades of work ahead of it. GM isn't faring poorly in the EV arena, either, so unlike other automakers that have rekindled V8 production, this isn't a crutch. GM's going where the money is, and that's just good business.
Why GM is Investing Almost $1 Billion in Combustion Engines While Others Go Electric first appeared on Autoblog on May 29, 2025
This story was originally reported by Autoblog on May 29, 2025, where it first appeared.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hill
43 minutes ago
- The Hill
Puerto Rico is Trump's perfect partner in reshoring
President Trump recently signed an executive order to bring pharmaceutical manufacturing back to the U.S. by streamlining the process for the Food and Drug Administration to approve pharmaceutical manufacturing plants. This is the latest in the Trump administration's agenda to protect national security and create American jobs by promoting the reshoring of critical supply chains that Americans rely on every day. These efforts are coupled with international tariffs to encourage domestic manufacturing. Reshoring pharmaceutical manufacturing is not only dire for American national security, but it could have resounding economic impacts across the country. One U.S. jurisdiction that is ready and in a perfect position to partner in this effort is Puerto Rico, where pharmaceutical manufacturing is already a more than $50 billion industry. With complementary efforts underway in Congress and on the island, the White House should look to Puerto Rico as America's pharmaceutical powerhouse while not trapping the island in its current territory status by hindering a future transition to statehood that would further boost the island's manufacturing ability. As a territory, the island is part of the U.S. customs zone and is not subject to U.S. tariffs, and everything that is made in Puerto Rico is 'Made in the USA.' Yet, that same territory status has limited Puerto Rico's economic development by creating persistent uncertainty, underinvestment and an unequal playing field for economic competition. The territory status is unpopular on the island, and Puerto Rican voters have voted in favor of statehood four consecutive times, most recently last November. Trump and Congress have the opportunity of a generation to leverage the pharmaceutical infrastructure and workforce in Puerto Rico to achieve their agenda while also turbocharging the economy on the island, and they have the perfect ally in Puerto Rico to do it with — the island's Republican Gov. Jenniffer González-Colón. González-Colón is leading an ambitious agenda to reshape the national narrative about the island and its people — and ultimately achieve statehood for Puerto Rico. Aligning with the Trump administration's vision to reshore advanced manufacturing of critical products, she issued an executive order in late March and reached out to top White House officials to offer Puerto Rico's well-established, yet currently underutilized, manufacturing capacity as an economic engine to help grow American prosperity. González-Colón's executive order promotes the relocation of overseas manufacturing of pharmaceuticals and other products to Puerto Rico. Much like Trump's executive order, it eliminates barriers and streamlines the process for businesses to move to the island. This action is complementary to the Medical Manufacturing, Economic Development and Sustainability Act, which was recently reintroduced and incentivizes pharmaceutical manufacturing on the island and throughout economically distressed zones across the United States. The bill is designed to attract business to the island in a way that invests in the people of Puerto Rico. It does this by providing an incentive for medical manufacturing facilities to relocate to economically distressed zones, with an incentive dependent on the number of jobs created to ensure money is flowing back into communities. The incentive itself is based on economic factors and applies to communities throughout the United States — an appropriately wide scope that comports with Trump's strong desire to reshore large amounts of production in a short time frame. By tethering the tax credits to what manufacturers invest directly into wages, salaries and real middle-class benefits, the proposal creates good-paying, quality American jobs. Reshoring to Puerto Rico would mean that critical pharmaceuticals and medical devices, as well as other products that are currently manufactured overseas in China and other nations, would now be produced in America. This would create thousands of well-paying manufacturing jobs that Puerto Rico needs to turbocharge the modest economic progress it's made in recent years. The increased consumer demand on the island would help boost the approximately $70 billion in annual interstate commerce, resulting in more jobs and profits stateside. Puerto Rico is a natural partner in reshoring the medical and pharmaceutical manufacturing industry within U.S. borders. The island's leaders share in the White House's vision of a more prosperous pharmaceutical manufacturing industry and are working to ensure reshoring efforts do not trap Puerto Rico in its current territory status but instead enable it to reach its full potential as an engine of economic growth and prosperity as a future state of our Union. Manufacturing makes America stronger, especially when it lifts up communities and the hard-working American citizens that make 'Made in the USA' a possibility, including those in Puerto Rico.
Yahoo
an hour ago
- Yahoo
Cooper Companies Second Quarter 2025 Earnings: EPS Misses Expectations
Revenue: US$1.00b (up 6.3% from 2Q 2024). Net income: US$87.7m (down 1.3% from 2Q 2024). Profit margin: 8.7% (down from 9.4% in 2Q 2024). The decrease in margin was driven by higher expenses. EPS: US$0.44 (down from US$0.45 in 2Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 39%. Looking ahead, revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 8.2% growth forecast for the Medical Equipment industry in the US. Performance of the American Medical Equipment industry. The company's shares are down 13% from a week ago. While earnings are important, another area to consider is the balance sheet. See our latest analysis on Cooper Companies' balance sheet health. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
2 hours ago
- Yahoo
Hegseth challenges China in its own backyard
Defense Secretary Pete Hegseth on Saturday in Singapore attempted to woo Asian defense leaders to Washington's side as he warned of the 'imminent' threat China poses to the Indo-Pacific region. Hegseth, who took the stage at the Shangri-La Dialogue, sought to seize on a gap China created in declining to send its own defense minister to the major annual gathering of diplomats, military officials and business leaders — an opportunity for the U.S. to make inroads with Asian countries. 'Here in the Indo-Pacific, our futures are bound together,' Hegseth told attendees. 'We share your vision of peace and stability, of prosperity and security. And we are here to stay.' 'And as a matter of fact, we are here this morning, somebody else isn't,' he added. Hegseth's trip to Singapore — his second visit to the region as Pentagon chief — takes place amid the backdrop of heightened rhetoric between Washington and Beijing, which President Trump accused Friday of violating a temporary trade deal. European and Indo-Pacific countries have found themselves at a crossroads as of late, increasingly pulled between the competing interests of the U.S. and China as both struggle for dominance. There's also uncertainty in the region over the U.S.'s commitment to the defense of Taiwan, which China has threatened to overtake, a potential reality Hegseth played into. 'There's no reason to sugarcoat it. The threat China poses is real, and it could be imminent,' he said, adding that any move on Taipei by Beijing 'would result in devastating consequences for the Indo-Pacific and the world.' In an attempt to sway Indo-Pacific nations, Hegseth promised continued American partnership and support to those wary of the Trump administration's commitment to the region. But the pledges came with a caveat repeated in Europe, Africa and elsewhere in the world: a call for an increase in defense spending. 'We ask, and indeed we insist, that our allies and partners do their part on defense,' he said. 'Sometimes that means having uncomfortable and tough conversations.' The Shangri-La Dialogue, put on by the International Institute for Strategic Studies, traditionally gives U.S. defense leaders a soapbox to lay out America's strategy in the Indo-Pacific, with an audience of senior officials from across the globe. China, instead of sending its defense minister, sent only an academic delegation to the gathering. Hegseth took advantage of this absence and delivered the Trump administration's most concrete stance on U.S. security policy in the region since the president took office in January, pledging American support for allies while painting China as the common enemy. 'We do not seek conflict with communist China. … But we will not be pushed out of this critical region, and we will not let our allies and partners be subordinated and intimidated,' Hegseth said. 'It has to be clear to all that Beijing is credibly preparing to potentially use military force to alter the balance of power in the Indo Pacific,' he continued. While China has not sought war with any nation, it has flexed its military and economic might in the seas around East and South East Asia, attempting to dominate vital shipping lanes via its powerful navy and man-made islands laden with military equipment. Beijing has also built up its nuclear and conventional arsenals, amassing vessels for a navy that now outstrips the U.S. Navy in number of ships. And an ever looming presence is China's firm eye on Taiwan, which it views as its own territory and has vowed to 'reunify' with the island, using force if necessary. To that end, Beijing has increased war games around Taiwan and stepped up political pressure. The U.S. has made clear, however, that it will not be pushed from the region, with tens of thousands of troops based in Japan and South Korea, and several U.S. owned or maintained military bases in Australia, the Philippines and Papua New Guinea. Hegseth affirmed the U.S. alliance in the region when he visited the Philippines and Japan in March. The Pentagon also announced the development of a new defense strategy in May centered on 'deterring' China in the region and 'increasing burden-sharing' with international partners. But in Saturday's speech Hegseth expanded on Washington's plan, which includes improving U.S. forward force posture, rebuilding defense industrial bases, and helping allies and partners strengthen their defense capabilities. The pledges came, however, with an all-too-expected push for countries to ramp up their own defense spending, something the U.S. has already pushed its European allies to do. 'It doesn't make sense for countries in Europe to [spend more] while key allies in Asia spend less on defense in the face of an even more formidable threat — I've mentioned North Korea,' Hegseth said. While he didn't mention any specific spending goal, it is speculated that Hegseth will push Asian nations to increase defense spending to 5 percent of gross domestic product (GDP)— the new spending goal for NATO members in Europe. Pentagon policy chief Elbridge Colby hinted as much when he posted to the social media platform X on Wednesday that 5 percent 'is the new standard for our allies around the world, especially Asia.' Asian countries spent an average of 1.5 percent of GDP on defense in 2024 — a figure that has stayed constant over the last decade — but spending on weapons is spiking amid a darkening security outlook, according to a study released Wednesday by the International Institute for Strategic Studies. To nudge things along, Hegseth suggested on Saturday that European allies focus on security on their own continent, freeing up the U.S. to zero in on Chinese aggression in the Indo-Pacific. 'We would much prefer that the overwhelming balance of European investment be on that continent, so that as we partner there, which we will continue to do, we're able to use our comparative advantage as an Indo-Pacific nation to support our partners here,' he said during a Q&A portion after his speech. Hegseth's comments mark a turning point in his usual messaging, which has heavily centered around domestic issues such as protecting the U.S. southern border, restoring the 'warrior ethos,' and countering so-called 'woke' initiatives, including diversity, equity and inclusion programs, in the military. He still mentioned those issues, but played to a more international audience on Saturday. 'We are not here to pressure other countries to embrace or adopt our politics or ideology. We are not here to preach to you about climate change or cultural issues,' Hegseth said. 'We respect you, your traditions and your militaries. And we want to work with you where our shared interests align.' It's unclear how Hegseth's message was met by allies in the region, but China was certainly rankled, calling his comments 'steeped in provocations and instigation.' 'Mr. Hegseth repeatedly smeared and attacked China and relentlessly played up the so-called 'China threat,'' the Chinese embassy in Singapore wrote on its Facebook page. 'As a matter of fact, the U.S. itself is the biggest 'troublemaker' for regional peace and stability.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
